AI assistant
UNITED THERAPEUTICS Corp — Director's Dealing 2019
Feb 27, 2019
30320_dirs_2019-02-27_7d8bc311-ce36-44d2-8f3f-1c20dc89b15f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: UNITED THERAPEUTICS Corp (UTHR)
CIK: 0001082554
Period of Report: 2019-02-27
Reporting Person: EDGEMOND JAMES (CFO and Treasurer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-02-27 | Stock Options | $111.00 | A | 56512 | Acquired | 2028-03-15 | Common Stock (56512) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 566 | Direct |
Footnotes
F1: Includes 194 shares acquired on March 2, 2018 and 144 shares acquired on September 4, 2018, under the United Therapeutics Corporation Employee Stock Purchase Plan ("ESPP")
F2: These performance-based stock options were initially awarded on March 15, 2018, subject to a one-year performance condition tied to company-wide milestone performance for 2018, which was determined on February 27, 2019. Number of stock options reported represents the number of options earned based on milestone performance.
F3: These stock options vest in one-third increments on each of March 15, 2019, 2020 and 2021.